OTC Healthcare in Kazakhstan
Euromonitor International's OTC Healthcare in Kazakhstan market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 12 | Publication date: Jan 2007
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; Vitamins and dietary supplements; Wound treatments
Executive summary
Economic performance stimulates OTC healthcare growth
Excluding Russia, Kazakhstan is the largest of the former Soviet republics, and possesses enormous fossil fuel reserves, along with plentiful supplies of other minerals and metals. As a result the country enjoyed strong economic growth throughout the review period due to its booming energy industry. Economic reform, good harvests and growing foreign investment were also contributory factors. This led to consumers’ incomes rising, which enabled them to buy more expensive OTC healthcare products. This was evident in both staple goods such as cough, cold and allergy remedies, and also in increased interest in new offerings such as eye care, adult mouthcare and calming and sleeping products.
Manufacturer developments stimulate market
Large manufacturers of OTC healthcare products in Kazakhstan engaged in efforts to develop the OTC healthcare market in the country in 2005. Players are attempting to offer products with new, modern and, convenient formulations in attractive packaging, that appeal to the country’s increasingly sophisticated consumer base.
Vitamins and dietary supplements remain in demand
Sales of vitamins and dietary supplements remained popular in Kazakhstan in 2005 due to continued consumption of such products by consumers who believe such products may reduce the possibility of contracting cancer following the Chernobyl nuclear disaster of the 1980s. However, while vitamins and dietary supplements continued to account for a notable proportion of total OTC healthcare value, they saw a poor performance in current value terms in 2005 due to falling prices.
Greater advertising and promotion stimulates sales
Increased investment in advertising expenditure boosted the market’s performance in 2005, with more OTC healthcare products being advertising on television, radio, and in newspapers. Placement of POS materials in drugstores and strategic merchandising were also important factors, underpinned by offers and competitions for both consumers and industry employees, such as wholesalers and pharmacists.
Multinationals in a strong position
Multinational companies accounted for the majority of OTC healthcare sales in Kazakhstan in 2005, and are likely to remain important in coming years. With consumers’ incomes and the country’s economic prosperity expected to continue rising as a result of rising revenue from sales of its fossil fuel reserves, better quality products will become more affordable. Moreover, an increasing number of consumers are expected to take more interest in new offerings previously considered non-essential. Multinationals’ greater ability to invest in advertising and promotion will underpin their growing share of this expanding market.
Rapid growth predicted as market development gathers pace
Positive growth is expected over the forecast period, with a dynamic performance from nascent product categories such as child-specific OTC healthcare and burgeoning niches such as adult mouthcare. These are still likely to remain comparatively marginal concerns however. In actual terms, the most significant gains will be in the core categories of cough, cold and allergy remedies and vitamins and dietary supplements, where demand is growing, a product of gradually rising disposable incomes and multinational development of the nation-state into an embryonic capitalist system.
Table of contents
OTC HEALTHCARE IN KAZAKHSTAN : MARKET INSIGHT
1. EXECUTIVE SUMMARY
2. OPERATING ENVIRONMENT
2.1 OTC Registration and Classification
2.2 Vitamins & Dietary Supplements Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 De-listing or De-reimbursement
2.7 Traditional Remedies
2.8 Homeopathy
2.9 Generics
2.10 Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 2000-2005
2.11 Life Expectancy
Table 2 Life Expectancy at Birth 2000-2005
3. OTC HEALTHCARE SALES
3.1 Market Performance
Table 3 Retail Sales of OTC Healthcare by Sector: Value 2000-2005
Table 4 Retail Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
3.2 Switches
3.3 Competitive Environment
Table 5 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 6 OTC Healthcare Brand Shares by Retail Value 2002-2005
3.4 Leading Company Profile: Khimpharm OJSC / Santo
Summary 1 Khimpharm OJSC/Santo Operational Indicators 2005
3.5 Leading Company Profile: Nobel AFF
Summary 2 Nobel AFF: Operational Indicators 2005
3.6 New Product Developments
3.7 Retail Distribution
Table 7 Retail Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 8 Retail Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
3.8 Retailer Activity and Private Label Trends
3.9 Forecast Market Performance
Table 9 Forecast Retail Sales of OTC Healthcare by Sector: Value 2005-2010
Table 10 Forecast Retail Sales of OTC Healthcare by Sector: % Value Growth 2005-2010
4. DEFINITIONS